AICTE sponsored QIP on “Strategies in managing quality of biologicals and biosimilars”
Start Date: September 17, 2018
End Date: September 29, 2018
New regulations, healthcare expenditure cuts and advances in manufacturing techniques have determined the appearance of a new market for biosimilars, which is comparable to that of generic drugs. This QIP will equip the participants with the required expertise and knowledge about the challenging biological and biosimilar molecules.
Objectives of the QIP:
1. To understand the quality specifications and regulations of biosimilar and biologicals.
2. To appreciate the challenges involved in discovery, engineering and evaluation of biopharmaceuticals.
3. To analyse market dynamics of biopharmaceuticals globally.
Registration deadline: 10 September 2018
CLICK here to download the brochure
Centre for cGMP, MAHE, Manipal, Bags the Prestigious India Pharma Awards 2023 for Excellence in Quality Assurance
Dr Vamshi Krishna T Baggs Awards at ICHTR 2023
Dr S G Vasantharaju, Received Best Poster Award at NAMSCON 2023
Ms Niharika Gaddam Research scholar, Department of Pharmaceutical Quality Assurance, MCOPS received best poster award at TRDDCON 2023
Alumni Guest Talk by Dr Sajjad Fazal, Public Health Specialist, Canada